The North Texas Angel Network has invested $125,000 in Corganics, a company focused on providing accessible cannabinoid therapy alternatives, indicating strong growth and support in the health sector.

Information on the Target

Corganics is a dedicated company with a mission to simplify access to cannabinoid therapy across the United States. By focusing on high-quality, organic ingredients and eco-friendly packaging, Corganics aims to support wellness while promoting responsible cannabis use. The company is particularly focused on offering alternatives to opioids, which positions its products in a unique market segment often accessed through healthcare professionals, such as doctors and hospitals.

This strategic marketing approach not only enhances Corganics' credibility but also fosters a community that advocates for responsible cannabinoid therapy. With the recent investment from the North Texas Angel Network (NTAN), Corganics is poised for further growth, including the addition of new team members and the expansion of their product offerings.

Industry Overview in the United States

The cannabinoid therapy industry in the United States has witnessed remarkable growth in recent years, driven by increasing consumer demand for alternative health solutions. As cannabis legal